BioCatalystWatch
CGTXWorkspace / CGTX / OverviewCompany library
COGNITION THERAPEUTICS INC logo

COGNITION THERAPEUTICS INC

COGNITION THERAPEUTICS INC (CGTX)

Website

Price
Market cap
Next catalystSecond half of 2027, after the last participants have completed 18 months of treatmentZervimesine (CT1812) — START and prior Alzheimer’s studies · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Zervimesine (CT1812)

Sigma-2 receptor complex

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Zervimesine (CT1812)

Sigma-2 receptor complex

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Zervimesine (CT1812)

Sigma-2 receptor complex

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Zervimesine (CT1812)

Sigma-2 receptor complex

PreINDP1P2FilingApproved
Upcoming / outlook

History / paused

Zervimesine (CT1812)

Sigma-2 receptor complex

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status
6M6M
3M

Market Reaction / Supply Context

Market Structure

CGTX PR & News

PR & News

CGTX SEC archive